BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Silence Therapeutics plc 

Centre Point
103 New Oxford Street
London    WC 1A 1DD  United Kingdom
Phone: 44-0-20-73071620 Fax: 44-0-20-73071680


SEARCH JOBS


Industry
Biotechnology






 Company News
MiReven, Silence Therapeutics plc Ink Collaboration 8/22/2012 11:00:58 AM    More...
Silence Therapeutics plc - Admission of Shares and Board Update 8/2/2012 1:10:23 PM    More...
Silence Therapeutics plc Announces Safe and Effective Dose Successfully Identified in Phase I Study of Atu027 and Potential Fund Raising 6/6/2012 11:01:30 AM    More...
New Data from Silence Therapeutics plc's Atu027 Anticancer Trial Published at American Society of Clinical Oncology 5/17/2012 10:47:40 AM    More...
Silence Therapeutics plc' Partner, Quark Pharmaceuticals Inc., Extends its Agreement With Pfizer Inc. (PFE) to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 5/3/2012 7:02:19 AM    More...
Silence Therapeutics plc: Unaudited Preliminary Results for the Year Ended 31 December 2011 3/21/2012 10:27:17 AM    More...
Silence Therapeutics plc Forms Scientific Advisory Board and Forms Two New Research Collaborations to Further Strengthen Liver Pipeline 3/21/2012 10:22:34 AM    More...
Silence Therapeutics plc and Other Opponents of Tuschl I Patent Succeed in Limiting Scope and Ambiguity in the Patent 3/9/2012 10:11:05 AM    More...
Silence Therapeutics plc Announces Board Changes and Appointment of New Chief Executive Officer 2/10/2012 6:33:23 AM    More...
Silence Therapeutics plc Signs Collaboration with miRagen Therapeutics to Evaluate Delivery of Novel microRNA-based Therapeutics 1/9/2012 10:34:16 AM    More...
1234567

//-->